Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-000734

Options or other derivatives

  • CHIEF EXECUTIVE OFFICER acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Williams Gregory C. · CHIEF EXECUTIVE OFFICER

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-12 Grant or award : show line 1 in the form Stock Options +300,000 300,000 D
Loading xslF345X03/form4-02172021_030201.xml…